We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Warner Chilcott Hit With Suit Over IPO Prospectus

Law360 (November 2, 2006, 12:00 AM EST) -- Drug maker Warner Chilcott Ltd. deliberately failed to disclose that it had pulled one of its top earning drugs from shelves amid a federal antitrust investigation just days before its initial public offering, shareholders have alleged in a newly filed class action securities suit.

Filed by plaintiffs firm Lerach Coughlin Stoia Geller Rudman & Robbins in the U.S. District Court for the Southern District of New York, the complaint claims that Warner made misleading statements in its IPO prospectus, omitting details about a Federal Trade Commission...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.